| 注册
首页|期刊导航|山西医科大学学报|白藜芦醇纳米混悬剂的制备及体外初步评价

白藜芦醇纳米混悬剂的制备及体外初步评价

李梦婷 褚琳 何宁 刘家佳 徐维平

山西医科大学学报2024,Vol.55Issue(7):908-915,8.
山西医科大学学报2024,Vol.55Issue(7):908-915,8.DOI:10.13753/j.issn.1007-6611.2024.07.013

白藜芦醇纳米混悬剂的制备及体外初步评价

Preparation and preliminary evaluation in vitro of resveratrol nanosuspensions

李梦婷 1褚琳 1何宁 1刘家佳 2徐维平3

作者信息

  • 1. 安徽中医药大学药学院,合肥 230012
  • 2. 中国科学技术大学附属第一医院,安徽省立医院眼科
  • 3. 安徽中医药大学药学院,合肥 230012||中国科学技术大学附属第一医院,安徽省立医院药剂科||安徽省老年医学研究所,中国科学技术大学附属第一医院,安徽省立医院老年医学科
  • 折叠

摘要

Abstract

Objective To prepare and in vitro evaluate the resveratrol(RES)nanosuspension.Methods RES nanosuspensions were prepared by precipitation method.With the average particle size and the polydispersity index(PDI)as evaluation indexes,the orthogonal test was used to optimize the formulation process.The freeze-dried powder of nanosuspension was prepared by freeze-drying method and characterized.The in vitro release of the preparation was studied by dialysis bag method.The ARPE-19 cell injury model was estab-lished by high glucose stimulation,and the effect of RES nanosuspension on the cell viability was evaluated by CCK-8 method.Results The optimal prescription process of RES was as follows:the concentration of RES was 6 mg/mL,the mass ratio of two stabilizers(PVP K17∶HPMC)was 2∶1,and the mass ratio of RES and stabilizer was 1∶2,and 5%mannitol was freeze-dried protective agent.The RES nanosuspension was relatively regular granule,with a drug loading of 28.04%and a cumulative release of 91.27%within 36 h.Compared with RES,RES nanosuspension pretreatment significantly increased the viability of ARPE-19 cells damaged by high glucose.Conclusion RES nanosuspension could increase the release rate of RES in vitro,and could attenuate the damage of ARPE-19 cells by high glucose and improve the cell survival rate.

关键词

白藜芦醇/纳米混悬剂/ARPE-19细胞/高糖致细胞损伤/体外累计释放率

Key words

resveratrol/nanosuspension/ARPE-19 cells/high glucose-induced cell damage/in vitro cumulative release rate

分类

医药卫生

引用本文复制引用

李梦婷,褚琳,何宁,刘家佳,徐维平..白藜芦醇纳米混悬剂的制备及体外初步评价[J].山西医科大学学报,2024,55(7):908-915,8.

基金项目

国家自然科学基金项目(52072360) (52072360)

山西医科大学学报

OACSTPCD

1007-6611

访问量0
|
下载量0
段落导航相关论文